Sign In
Buy LLY
$1,116.11
-5.06 (-0.451%)
At Close: Aug 04, 2026
Eli Lilly (LLY) Beats Q1 Earnings and Revenue Estimates
08:55am, Thursday, 30'th Apr 2026
Eli Lilly (LLY) came out with quarterly earnings of $8.55 per share, beating the Zacks Consensus Estimate of $7.06 per share. This compares to earnings of $3.34 per share a year ago.
Consumer demand for blockbusters Mounjaro and Zepbound helped offset declining prices for the drugs.
Eli Lilly stock jumps 6% after strong earnings and raised guidance
07:19am, Thursday, 30'th Apr 2026
Eli Lilly reported stronger-than-expected first-quarter earnings and revenue on Thursday, driven by robust demand for its blockbuster weight-loss and diabetes drugs, prompting the company to raise its
Eli Lilly Stock Jumps on Earnings Beat as Zepbound and Mounjaro Sales Skyrocket
07:08am, Thursday, 30'th Apr 2026
Revenue tied to Lilly's Zepbound and Mounjaro more than doubles from the same period last year.
Lilly reports first-quarter 2026 financial results, raises full year guidance, and highlights momentum of new medicines
06:45am, Thursday, 30'th Apr 2026
Revenue in Q1 2026 increased 56% to $19.8 billion primarily driven by volume growth, partially offset by lower realized prices from Mounjaro and Zepbound. Q1 2026 EPS increased by 170% to $8.26 on a r
Eli Lilly Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
02:47am, Thursday, 30'th Apr 2026
Eli Lilly and Company (NYSE:LLY) will release earnings for its first quarter before the opening bell on Thursday, April 30.
Eli Lilly Stock Could Rise Sharply After Earnings
02:00pm, Wednesday, 29'th Apr 2026
Eli Lilly and Company has declined over 20% since January despite strong anticipated Q1 results and has not participated in the recent market rally. Options market positioning is extremely bearish wit
Here's How Much Traders Expect Eli Lilly Stock To Move After Earnings
01:47pm, Wednesday, 29'th Apr 2026
Eli Lilly is scheduled to report its latest quarterly earnings ahead of the opening bell Thursday, with shares seen potentially falling to their lowest level in months following the report.
Artisan Global Opportunities Fund Q1 2026 Portfolio Activity
11:13am, Wednesday, 29'th Apr 2026
During the quarter, we initiated new positions in Edwards Lifesciences, Eli Lilly and Roblox. In addition to Linde, Shopify and Amazon, we also added to Woodward and Spotify during the quarter. We end
Eli Lilly investors are eager for Foundayo insight after early launch data
06:02am, Wednesday, 29'th Apr 2026
Eli Lilly investors will be searching for something they won't find in any first-quarter financial figures reported on Thursday: insight into the launch of weight-loss pill Foundayo.
Is Eli Lilly Stock Undervalued at $870? 1 Top Wall Street Analyst Thinks So
06:15pm, Tuesday, 28'th Apr 2026
One analyst thinks Eli Lilly's shares boast significant upside potential. The company's weight loss portfolio could help drive solid growth over the medium term.
Pharmaceutical Stock Pulling Back Before Earnings
02:44pm, Tuesday, 28'th Apr 2026
Eli Lilly And Co (NYSE:LLY) stock is down 0.3% to trade at $865.41 at last glance, pulling back alongside the broader market.
LLY Expands Oncology Pipeline With $2.3B Ajax Therapeutics Acquisition
01:36pm, Tuesday, 28'th Apr 2026
Lilly is set to acquire Ajax Therapeutics for up to $2.3B, gaining a novel JAK2 inhibitor as it ramps up oncology bets and targets unmet needs in MPN treatment.
Earnings Preview: Pfizer (PFE) Q1 Earnings Expected to Decline
11:01am, Tuesday, 28'th Apr 2026
Pfizer (PFE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Profluent, Lilly partner in genetic medicine deal worth up to $2.25 billion
07:18am, Tuesday, 28'th Apr 2026
AI firm Profluent said on Tuesday it has struck a multi-program research collaboration with U.S. drugmaker Eli Lilly worth up to $2.25 billion to develop AI-designe
